Nexalin Technology, Inc. cotiza a 3.36 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia,…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-3.30 | $-3.30 | $-3.90 | $-3.90 |
| Estimado | $-3.00 | $-3.00 | $-3.60 | $-3.60 |
| Sorpresa | -10.0% | -10.0% | -8.3% | -8.3% |
| Métrica | NXL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 79.7% | 57.0% | +22.6% |
| Operating Margin | -2781.7% | -38.6% | -2743.1% |
| Net Margin | -2725.8% | -33.6% | -2692.2% |
| FCF Margin | — | -13.9% | — |
| ROE | -219.4% | -40.4% | -179.0% |
| ROA | -177.4% | -32.0% | -145.4% |
| Current Ratio | 4.85 | 2.84 | +2.01 |
| Debt / Equity | — | 0.28 | — |